Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

PRLD Prelude Therapeutics Inc

0,736

0,0239 (3,36%)

08 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Prelude Therapeutics (NASDAQ:PRLD)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Prelude Therapeutics Charts.

Prelude Therapeutics (NASDAQ:PRLD)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Prelude Therapeutics Charts.

News Prelude Therapeutics Inc

Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference
Mittwoch 5 März 2025 (3 Tage vor) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 14 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Prelude Therapeutics Inc News-Artikel

Velgraf Asset Management...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen